Skip to main content
China Health Group Limited logo

China Health Group Limited — Investor Relations & Filings

Ticker · 673 ISIN · BMG2107P2040 HKEX Human health and social work activities
Open in API
Filings indexed 1,188 across all filing types
Latest filing 2026-05-26 Legal Proceedings Report
Country HK Hong Kong
Listing HKEX 673

About China Health Group Limited

http://www.ch-groups.com

China Health Group Limited operates as an investment holding company dedicated to the comprehensive expansion of the massive health industry platform. The company's business model integrates strategic investment, mergers and acquisitions, and hospital development management. A principal operational segment is the distribution and trading of medical equipment and consumables, with services primarily directed toward the market in the People's Republic of China. Furthermore, the Group provides a range of healthcare services, including health management, physical examination, health information, and health derivative solutions.

Recent filings

Filing Released Lang Actions
INSIDE INFORMATION UPDATE ON THE LITIGATION
Legal Proceedings Report Classification · 84% confidence The document is an announcement made under the Hong Kong Listing Rules and Inside Information Provisions, providing an update on a litigation matter (civil judgment and next steps). It is clearly detailing the status and outcome of a lawsuit, without presenting any financial statements or report attachments. This fits the definition of a Legal Proceedings Report (Code: LTR).
2026-05-26 English
UPDATE IN RELATION TO THE DISCLAIMER OF OPINION ON GOING CONCERN SET OUT IN THE ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2025
Capital/Financing Update Classification · 90% confidence The announcement provides updates on the company’s financing measures to address auditors’ going concern disclaimer, including completed subscription agreements, a rights issue, bank borrowing renewal, and new share subscriptions. It focuses on capital-raising actions and changes in the capital structure rather than presenting a full financial report. Therefore, it falls under Capital/Financing Update.
2026-05-15 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing to the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for China Health Group Limited. It details movements in authorized and issued share capital, share options, and confirms compliance with listing rules and public float requirements. The document is a regulatory submission reporting share capital and shareholding movements, not a financial report, earnings release, or management discussion. It is not an announcement of voting results, nor a proxy statement, nor a capital raising update. It is a regulatory compliance filing specific to share capital movements and confirmations under HKEX rules. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other categories.
2026-05-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026
Share Issue/Capital Change Classification · 85% confidence The document is an FF301 Monthly Return filed to the Hong Kong Exchanges under Chapter 19B Listing Rules, detailing movements in authorised/registered share capital, issued shares, treasury shares, share options, confirmations, etc. It is a regulatory announcement focused on share issuances and capital structure changes. This aligns with the “Share Issue/Capital Change” category (SHA).
2026-04-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2026
Regulatory Filings Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly changes in share capital, share options, and other securities movements. It does not fit into categories like 10-K, ER, or IR, as it is a specific regulatory disclosure form for securities movements. Since it is a recurring regulatory filing regarding share capital changes, it is best classified as a Regulatory Filing (RNS).
2026-03-03 English
CANCELLATION OF SHARE OPTIONS
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from China Health Group Limited regarding the cancellation of previously granted share options. It details the board's decision to cancel 40,638,000 options and explains the impact on the remaining share mandate limits. This type of corporate action regarding share-based compensation and capital structure adjustments falls under the category of share issues or capital changes, specifically related to the management of equity instruments.
2026-02-13 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.